Patients completed the planned 12-month core study

Female patients who have reached menarche and who are sexually active must use double-barrier contraception, oral contraceptive plus barrier contraceptive, or must have undergone clinically documented total hysterectomy and/or ovariectomy, or tubal ligation

Written informed consent obtained from the patient and/or legal guardian on the patient's behalf in accordance with the national legislation

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

What this study is about